Patent ID: 11918629
Assignee: OMRIX BIOPHARMACEUTICALS LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 7:
8. A two-component mixture comprising (i) a plasma cryoprecipitate comprising: fibrinogen, and albumin in a range of 1.2 mg/ml to 3 mg/ml and (ii) thrombin; wherein the mixture comprises free calcium ions, total protein in a range of about 2.5 mg/ml to about 30 mg/ml, fibrinogen in a range of about 50% to less than 80% of total protein by weight; and wherein the plasma cryoprecipitate being depleted from plasmin and/or plasminogen, does not comprise tranexamic acid or aprotinin, and comprises factor XIII, fibronectin, and optionally one or more members selected from factor VIII, von Willebrand factor (vWF), and vitronectin.